|
|
Structural studies of amyloid beta globulomers with EPR spectroscopy |
| 5R01AG050687-04 |
GUO, ZHEFENG |
NIA |
2020 |
|
|
Role of microRNA-33 in Alzheimers disease |
| 5R01AG053500-05 |
KIM, JUNGSU |
NIA |
2020 |
|
|
Systematic profiling of lysosomes with age to improve proteostasis in Alzheimers |
| 5R01AG057342-03 |
KAO, AIMEE |
NIA |
2020 |
|
|
Regulation of gamma-secretase function in Alzheimers disease |
| 5R01AG058851-03 |
THATHIAH, AMANTHA |
NIA |
2020 |
|
|
Resolving selective vulnerability and disease progression in human Alzheimers brain via single-cell RNA-seq |
| 5R01AG059848-03 |
COBOS, INMA |
NIA |
2020 |
|
|
Genetic interaction of PICALM and APOE in Alzheimers disease |
| 5R03AG063287-02 |
ZHAO, ZHEN |
NIA |
2020 |
|
|
Dietary restriction and associated changes in gut microbiota to prevent Alzheimer disease |
| 5R21AG062378-02 |
SAMBAMURTI, KUMAR |
NIA |
2020 |
|
|
Electronic Financial Indicators of Neurodegenerative Disease |
| 5R21AG062679-02 |
WILD, KATHERINE |
NIA |
2020 |
|
|
Spinal muscular atrophy: Mechanisms & treatment strategies. |
| 5R01NS104218-02 |
MONANI, UMRAO |
NICHD |
2020 |
|
|
The gut brain axis: microbial impact on neural function |
| 5R01NS107475-03 |
ALKEMA, MARK |
NIDDK |
2020 |
